Keyphrases
Pancreatic Ductal Adenocarcinoma
100%
Gemcitabine
50%
Pancreatic Cancer
50%
BLM Helicase
41%
Chemotherapy
34%
Ulixertinib
31%
Ribosomal RNA Transcription
27%
Nucleolus
25%
Point mutation
23%
Colorectal Cancer
23%
RNA Polymerase I
23%
Pembrolizumab
21%
Targeted Therapy
21%
BRAF Inhibitor (BRAFi)
21%
Metastatic Disease
19%
Radiological Response
18%
ERK Inhibitor
18%
Cancer Model
18%
Nucleolar Localization Signal (NoLS)
18%
5-fluorouracil (5-FU)
17%
Mitogen-activated Protein Kinase
17%
Genotoxic Stress
17%
Recommended Phase 2 Dose
17%
Pancreatic Duct Cells
16%
Human rDNA
15%
TPL2
15%
Leucovorin
15%
Late Response
15%
Gastrointestinal Malignancies
15%
Chromosome Breakage
15%
Liposomal Irinotecan
15%
Topoisomerase II
15%
Paricalcitol
15%
Systemic Arteries
15%
Pseudoprogression
15%
Tosedostat
15%
Vorolanib
15%
X-82
15%
Cancer Patients
15%
Magnetic Resonance
15%
Gastroesophageal Junction Cancer
15%
Metastatic Hepatocellular Carcinoma
15%
Resectable Pancreatic Cancer
15%
CSF1R
15%
Metastatic Pancreatic Adenocarcinoma
15%
Nab-paclitaxel
15%
Everolimus
15%
Targeting Strategies
15%
Phase Ib Study
15%
HER Inhibition
15%
Medicine and Dentistry
Pancreas Adenocarcinoma
76%
Pancreas Cancer
54%
Cancer
42%
Immunotherapy
34%
Gemcitabine
31%
Diseases
27%
Metastatic Carcinoma
22%
Neoplasm
22%
Stroma
21%
Pembrolizumab
19%
Targeted Therapy
19%
Drug Conjugate
15%
Bloom Syndrome Helicase
15%
RNA Polymerase I
15%
Beta Chemokine
15%
Intraarterial Drug Administration
15%
Hepatocellular Carcinoma
15%
Irinotecan Sucrosofate
15%
Tosedostat
15%
Colorectal Liver Metastasis
15%
Epidermal Growth Factor Receptor 2
15%
Gamma Urogastrone
15%
Mitogen-Activated Protein Kinase
15%
Vorolanib
15%
Common Hepatic Artery
15%
Colony Stimulating Factor 1
15%
Colony Stimulating Factor Receptor
15%
Paricalcitol
15%
Chemokine Receptor
15%
Trametinib
15%
Solid Malignant Neoplasm
15%
Positron Emission Tomography
15%
RNA Transcription
15%
Tyrosine-Kinase Inhibitor
15%
Everolimus
15%
Protein Tyrosine Kinase
15%
Platelet Derived Growth Factor Receptor
15%
Copper Nanoparticle
15%
Gastrointestinal Cancer
15%
Drive
15%
Dabrafenib
15%
Interleukin 1 Receptor Associated Kinase 4
15%
Vasculotropin Receptor
15%
Fluorouracil
15%
Folinic Acid
15%
Ganglioglioma
15%
Ribosome RNA
15%
Capecitabine
15%
Chemotherapy
15%
Colorectal Carcinoma
13%
Biochemistry, Genetics and Molecular Biology
Helicase
49%
KRAS
44%
Topoisomerase
37%
DNA Topoisomerase
37%
Mitogen-Activated Protein Kinase
34%
Ribosomal RNA
34%
RNA Transcription
31%
Nucleolus
29%
RNA Polymerase I
24%
Carcinogenesis
23%
RNA Sequence
22%
Clinical Study
19%
Transcription
17%
Immunocompetent Cell
17%
Fibroblast
16%
Bloom Syndrome
16%
Epidermal Growth Factor Receptor
15%
Gene Mutation
15%
Stromal Cell
15%
Drug Resistance
15%
Drive
15%
Conjugate
15%
Nuclear Localization Sequence
15%
Chromosome Breakage
15%
Point Mutation
15%
Ubiquitin-Conjugating Enzyme
15%
Heat Shock Protein
15%
Interleukin-1 Receptor-Associated Kinase
15%
IRAK4
15%
Isoform
15%
DNA Gyrase
15%
Serine
15%
Kinase
13%
Phosphotransferase
13%
Chromosome Instability
10%
Immunoprecipitation
10%
Protein Microarray
8%
C-Terminus
8%
Ubiquitin Ligase
7%
T Cell
7%
Cell Growth
7%
Dual-Specificity Phosphatase
6%
Cancer Cell
6%
Interleukin-1
6%
DNA RNA Hybridization
6%
Programmed Cell Death
6%
DNA Repair
5%
TRIM21
5%
Cell Cycle
5%
Mitosis
5%
